Drug Type Recombinant coagulation factor |
Synonyms recombinant human thrombin, Recombinant thrombin, Recothrom + [4] |
Target |
Mechanism prothrombin modulators(Prothrombin modulators), Thrombin replacements |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (26 Dec 2023), |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Country/Location | Organization | Date |
---|---|---|---|
Hemorrhage | CN | 26 Dec 2023 |
Phase 3 | 348 | ucoxybltbx(qcgndaombc) = gocukqiibf twxppqicqs (bugsttessl, 65.75 - 77.36) View more | Positive | 21 Jun 2023 | |||
Placebo | ucoxybltbx(qcgndaombc) = xpzrovaovc twxppqicqs (bugsttessl, 34.93 - 53.00) View more |